Molecular mechanisms of dopaminergic subset specification: fundamental aspects and clinical perspectives.
about
Diversity matters - heterogeneity of dopaminergic neurons in the ventral mesencephalon and its relation to Parkinson's DiseaseOtx2 Requires Lmx1b to Control the Development of Mesodiencephalic Dopaminergic NeuronsEmbryonic development of selectively vulnerable neurons in Parkinson's disease.Establishing diversity in the dopaminergic system.Admixing of MPTP-Resistant and Susceptible Mice Strains Augments Nigrostriatal Neuronal Correlates to Resist MPTP-Induced Neurodegeneration.Molecular Programming of Mesodiencephalic Dopaminergic Neuronal Subsets.Pitx3 and En1 determine the size and molecular programming of the dopaminergic neuronal pool.Dopamine and Acetylcholine, a Circuit Point of View in Parkinson's Disease.BMP/SMAD pathway promotes neurogenesis of midbrain dopaminergic neurons in vivo and in human induced pluripotent and neural stem cells.Mouse Fgf8-Cre-LacZ lineage analysis defines the territory of the postnatal mammalian isthmus.A novel floor plate boundary defined by adjacent En1 and Dbx1 microdomains distinguishes midbrain dopamine and hypothalamic neurons.Impact of the Chronic Omega-3 Fatty Acids Supplementation in Hemiparkinsonism Model Induced by 6-Hydroxydopamine in Rats.Maternal Vitamin D Prevents Abnormal Dopaminergic Development and Function in a Mouse Model of Prenatal Immune Activation.
P2860
Q28078561-BBA16E05-5D7C-4B8E-85D9-E412A950721DQ28550104-3DCF3F06-A14E-4A1C-ABAA-39A3931E4DD5Q33835242-117A4A52-0845-40C8-ACFC-AA5850A21055Q38598047-E443A71B-9D82-47FF-8D8F-EDE0F57B9D7CQ39298090-6AB29462-6065-4D32-9F46-F6E52CA0E938Q41050801-65351F9F-F83F-4898-973E-3F27C25831D5Q41363585-DF8B316C-3C05-4395-856C-AC003D4B7F95Q47178205-02975477-C206-46D5-ACF7-FA894ADCF5E0Q47872003-6C007781-8391-4123-BB27-DD9A5083A5FCQ48136803-B103799D-19F2-43C4-ACEE-78ACBD33C224Q48265173-2E835154-4A4C-4A12-8D1E-9D9D3385B62AQ48418240-7B8C8EB7-C28A-4A08-B637-ED104277ED30Q55430762-F4CE401E-7085-46C3-B858-374C2EF74709
P2860
Molecular mechanisms of dopaminergic subset specification: fundamental aspects and clinical perspectives.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Molecular mechanisms of dopami ...... cts and clinical perspectives.
@en
type
label
Molecular mechanisms of dopami ...... cts and clinical perspectives.
@en
prefLabel
Molecular mechanisms of dopami ...... cts and clinical perspectives.
@en
P2860
P1476
Molecular mechanisms of dopami ...... ects and clinical perspectives
@en
P2093
Jesse V Veenvliet
P2860
P2888
P304
P356
10.1007/S00018-014-1681-5
P577
2014-07-27T00:00:00Z